2-Phenylethylamine (PEA) Ameliorates Corticosterone-Induced Depression-Like Phenotype via the BDNF/TrkB/CREB Signaling Pathway
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Depression is a serious medical illness that is one of the most prevalent psychiatric disorders. Corticosterone (CORT) increases depression-like behavior, with some effects on anxiety-like behavior. 2-Phenethylamine (PEA) is a monoamine alkaloid that acts as a central nervous system stimulant in humans. Here, we show that PEA exerts antidepressant effects by modulating the Brain-derived neurotrophic factor (BDNF)/tropomyosin receptor kinase B (TrkB)/cAMP response element binding protein (CREB) signaling pathway in CORT-induced depression. To investigate the potential effects of PEA on CORT-induced depression, we first treated CORT (50 μM)-induced hippocampal neurons with 100 μM PEA for 24 h. We found that treatment with CORT altered dendritic spine architecture; however, treatment with PEA rescued dendritic spine formation via regulation of BDNF/TrkB/CREB signaling. Next, we used a mouse model of CORT-induced depression. Mice were treated with CORT (20 mg/kg) for 21 days, followed by assessments of a battery of depression-like behaviors. During the final four days of CORT exposure, the mice were treated with PEA (50 mg/kg). We found that CORT injection promoted depression-like behavior and significantly decreased BDNF and TrkB expression in the hippocampus. However, treatment with PEA significantly ameliorated the behavioral and biochemical changes induced by CORT. Our findings reveal that PEA exerts antidepressant effects by modulating the BDNF/TrkB/CREB signaling pathway in a mouse model of CORT-induced depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tail suspension test: A new method for screening antidepressants in mice
Steru, L., Chermat, R., Thierry, B., & Simon, P. (1985) · Psychopharmacology · doi:10.1007/bf00428203 · Cited by 3,534 · cited 1×
“The total duration of immobility induced by tail suspension test was measured according to the method of [76].”
MethodNeurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
Herman, J. P., & Cullinan, W. E. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10069-2 · Cited by 2,270 · cited 1×
“Dysregulation of the HPA axis is a common finding in depression, which results in increased circulating glucocorticoid levels in blood [5] and, as a result, leads to oxidative stress [6,7], glutamatergic excitotoxicity [8,9] and neuroinflammation [10].”
Cross-national epidemiology of DSM-IV major depressive episode
Bromet, E., Andrade, L. H., Hwang, I., Sampson, N. A., Alonso, J., de Girolamo, G., de Graaf, R., Demyttenaere, K., Hu, C., Iwata, N., et al. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-90 · Cited by 2,221
Neurotrophin-regulated signalling pathways
Reichardt, L. F. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1894 · Cited by 2,195
Nibuya, M., Morinobu, S., & Duman, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07539.1995 · Cited by 2,109 · cited 1×
“Chronic antidepressant treatments activates BDNF mRNA and protein expression in distinct regions of the brain [31], and pretreatment with antidepressants prevents stress-induced decreases in hippocampal BDNF expression [32].”
BackgroundNeurotrophin regulation of neural circuit development and function
Park, H., & Poo, M.-M. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3379 · Cited by 2,060 · cited 1×
“Brain-derived neurotrophic factor (BDNF) is a well-known growth factor that plays a critical role in several aspects of brain function, including neurogenesis, neuronal survival, neuronal maturation, synapse formation and synaptic plasticity in the brain [16,17].”
BackgroundWillner, P. (2005) · Neuropsychobiology · doi:10.1159/000087097 · Cited by 1,605 · cited 2×
“nhe onia, hich refers to loss of interest or pleasure, is a frequent sy pto of ajor epression in hu ans an is associate ith ysfunction of the re ar syste [58].”
BackgroundCa2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Autry, A. E., & Monteggia, L. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005108 · Cited by 1,390 · cited 3×
“B F and its receptor TrkB have important roles in the formation of neural circuits and are widely implicated in many neuropsychiatric disorders [18].”
BackgroundInfluentialDrug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling
Lüscher, C., & Malenka, R. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.017 · Cited by 1,105 · cited 1×
“We found that CORT administration modified dendritic spine density and morphology, which was related to synaptic function [49,50].”
BackgroundStructural plasticity and memory
Lamprecht, R., & LeDoux, J. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1301 · Cited by 1,010 · cited 1×
“Activity-dependent morphological changes in dendritic spines play essential roles in neural plasticity [41].”
BackgroundRossi, C., Angelucci, A., Costantin, L., Braschi, C., Mazzantini, M., Babbini, F., Fabbri, M. E., Tessarollo, L., Maffei, L., Berardi, N., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05059.x · Cited by 619
Dynamic visualization of local protein synthesis in hippocampal neurons
Aakalu, G., Smith, W. B., Nguyen, N., Jiang, C., & Schuman, E. M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00295-1 · Cited by 611
Feyissa, A. M., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.005 · Cited by 421 · cited 1×
“exposure of rodents to corticosterone (CORT) is widely used to induce depression-like behavior and neurochemical changes associated with MDD symptoms, including anhedonic and anxiety behaviors [11,12] and decreased levels of synaptic-related proteins [13,14].”
BackgroundThe HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain
Bellavance, M.-A., & Rivest, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00136 · Cited by 419
Alonso, M., Medina, J. H., & Pozzo-Miller, L. (2004) · Learning & Memory · doi:10.1101/lm.67804 · Cited by 412 · cited 1×
“BDNF/TrkB signaling increases dendritic spine density in hippocampal CA1 pyramidal neurons [55].”
BackgroundBrain-derived neurotrophic factor: role in depression and suicide
Dwivedi, Y. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5700 · Cited by 355
Shepard, J. D., Barron, K. W., & Myers, D. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02019-9 · Cited by 321 · cited 1×
“CORT exposure reduces open arm exploration in the EPM, indicating increased anxiety in the rodent [65,66].”
BackgroundDias, B. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00198-9 · Cited by 274 · cited 1×
“Chronic antidepressant treatments activates BDNF mRNA and protein expression in distinct regions of the brain [31], and pretreatment with antidepressants prevents stress-induced decreases in hippocampal BDNF expression [32].”
BackgroundKunugi, H., Ida, I., Owashi, T., Kimura, M., Inoue, Y., Nakagawa, S., Yabana, T., Urushibara, T., Kanai, R., Aihara, M., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300868 · Cited by 200 · cited 1×
“Chronic stress is an important risk factor for the development of major depression [2], and stress-induced dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is involved in the pathogenesis of depression [3,4].”
BackgroundReliability of the chronic mild stress model of depression: A user survey
Willner, P. (2017) · Neurobiology of Stress · doi:10.1016/j.ynstr.2016.08.001 · Cited by 198 · cited 2×
“The sucrose preference test was performed as described previously [47] to assess anhedonia in mice.”
BackgroundMethodKendler, K. S., & Gardner, C. O. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.136 · Cited by 181 · cited 1×
“Chronic stress is an important risk factor for the development of major depression [2], and stress-induced dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is involved in the pathogenesis of depression [3,4].”
BackgroundImipramine Induces Brain-Derived Neurotrophic Factor mRNA Expression in Cultured Astrocytes
Takano, K., Yamasaki, H., Kawabe, K., Moriyama, M., & Nakamura, Y. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12039fp · Cited by 70 · cited 1×
“The positive control, imipramine is a tricyclic antidepressant and dose-dependently increased BDNF mRNA expression [46].”
Background
Cited by
Dionisie, V., Ciobanu, A. M., Toma, V. A., Manea, M. C., Baldea, I., Olteanu, D., Sevastre-Berghian, A., Clichici, S., Manea, M., Riga, S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147483 · Cited by 78
Hyun, S.-A., Ko, M. Y., Jang, S., Lee, B.-S., Rho, J., Kim, K. K., Kim, W.-Y., & Ka, M. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049177 · Cited by 40
“Cell viability assay was described previously (Lee et al., 2020), in brief, for analysis of cell viability, 1 × 10 4 cells/well were seed in a 96 well plates and incubated for 24 h at 37 °C under humidified conditions (5% CO2 atmosphere).”
Self-citation
Metadata
- Authors
- Lee, Y.-J., Kim, H. R., Lee, C. Y., Hyun, S.-A., Ko, M. Y., Lee, B.-S., Hwang, D. Y., & Ka, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-11-30
- Volume
- 21
- Issue
- 23
- Pages
- 9103
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3107406382
- Cited by
- 71
- References
- 23
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.